Corrigendum: Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer

Yajuan Zheng¹, Guansheng Zhong², Kun Yu¹, Kefeng Lei^{1

3}, Qiong Yang¹

Affiliations

¹ Department of Breast and Thyroid Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
² Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
³ Department of General Surgery, The 7th Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Published Erratum

Yajuan Zheng et al. Front Oncol. 2020.

. 2020 Apr 9:10:482.

doi: 10.3389/fonc.2020.00482. eCollection 2020.

Yajuan Zheng¹, Guansheng Zhong², Kun Yu¹, Kefeng Lei^{1

3}, Qiong Yang¹

¹ Department of Breast and Thyroid Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
² Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
³ Department of General Surgery, The 7th Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.00148.].

Keywords: SEER program; clinic utility; metastatic breast cancer; nomogram; prognosis.

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer.
Zheng Y, Zhong G, Yu K, Lei K, Yang Q. Zheng Y, et al. Front Oncol. 2020 Feb 18;10:148. doi: 10.3389/fonc.2020.00148. eCollection 2020. Front Oncol. 2020. PMID: 32133290 Free PMC article.